Review ArticleReview Article
Open Access

Gestational diabetes mellitus

Eman M. Alfadhli
Saudi Medical Journal January 2015, 36 (4) 399-406; DOI: https://doi.org/10.15537/smj.2015.4.10307

References

  1. ↵
    1. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group
    (1979) Diabetes 28:1039–1057.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Blumer I,
    2. Hadar E,
    3. Hadden DR,
    4. Jovanovič L,
    5. Mestman JH,
    6. Murad MH,
    7. et al.
    (2013) Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 98:4227–4249.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. International Association of Diabetes and Pregnancy Study Groups Consensus Panel,
    2. Metzger BE,
    3. Gabbe SG,
    4. Persson B,
    5. Buchanan TA,
    6. Catalano PA,
    7. et al.
    (2010) International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 33:676–682.
    OpenUrlFREE Full Text
  4. ↵
    1. World Health Organization
    (2013) Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy (World Health Organization, Geneva (CH)) Available from: http: //130.14.29.110/books/NBK169024.
  5. ↵
    1. Bevier WC,
    2. Jovanovic-Peterson L,
    3. Peterson CM
    (1995) Pancreatic disorders of pregnancy. Diagnosis, management, and outcome of gestational diabetes. Endocrinol Metab Clin North Am 24:103–138.
    OpenUrlPubMed
  6. ↵
    1. American Diabetes Association. Diagnosis and classification of diabetes mellitus
    (2011) Diabetes Care 34(Suppl 1):S62–S69.
    OpenUrlFREE Full Text
  7. ↵
    1. Agarwal MM,
    2. Dhatt GS,
    3. Shah SM
    (2010) Gestational Diabetes Mellitus Simplifying the International Association of Diabetes and Pregnancy diagnostic algorithm using fasting plasma glucose. Diabetes Care 33:2018–2020.
    OpenUrlAbstract/FREE Full Text
    1. Dahanayaka NJ,
    2. Agampodi SB,
    3. Ranasinghe OR,
    4. Jayaweera PM,
    5. Wickramasinghe WA,
    6. Adhikari AN,
    7. et al.
    (2012) Inadequacy of the risk factor based approach to detect gestational diabetes mellitus. Ceylon Med J 57:5–9.
    OpenUrlPubMed
    1. Lacaria CS,
    2. Ghio A,
    3. Lemmi P,
    4. Battini L,
    5. Resi V,
    6. Volpe L,
    7. et al.
    (2011) Epidemiologic Implications of the New Diagnostic Criteria for Gestational Diabetes (International Diabetes Federation 2011. World Diabetes Congress; Dubai (UAE): 4-8 December).
    1. Hutton E,
    2. Man G,
    3. Allan C,
    4. Soldatos G
    The Changing Prevalence of GDM Post Adoption of the New Proposed International Association of the Diabetes and Pregnancy Study Groups (IADPSG) Guidelines. Available from: http: //ads-adea-2012.m.asnevents.com.au/schedule/session/453/abstract/1596.
    1. Jenum AK,
    2. Mørkrid K,
    3. Sletner L,
    4. Vangen S,
    5. Torper JL,
    6. Nakstad B,
    7. et al.
    (2012) Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study. Eur J Endocrinol 166:317–324.
    OpenUrlAbstract/FREE Full Text
    1. Mission JF,
    2. Ohno MS,
    3. Cheng YW,
    4. Caughey AB
    (2012) Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol 207:326.
    OpenUrlPubMed
    1. Morikawa M,
    2. Yamada T,
    3. Akaishi R,
    4. Nishida R,
    5. Cho K,
    6. Minakami H
    (2010) Change in the number of patients after the adoption of IADPSG criteria for hyperglycemia during pregnancy in Japanese women. Diabetes Res Clin Pract 90:339–342.
    OpenUrlCrossRefPubMed
    1. Reyes-Muñoz E,
    2. Parra A,
    3. Castillo-Mora A,
    4. Ortega-González C
    (2012) Effect of the diagnostic criteria of the International Association of Diabetes and Pregnancy Study Groups on the prevalence of gestational diabetes mellitus in urban Mexican women: a cross-sectional study. Endocr Pract 18:146–151.
    OpenUrlCrossRefPubMed
    1. Sacks DA,
    2. Hadden DR,
    3. Maresh M,
    4. Deerochanawong C,
    5. Dyer AR,
    6. Metzger BE,
    7. et al.
    (2012) Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel-Recommended Criteria The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 35:526–528.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Moses RG
    (2012) Gestational diabetes mellitus: implications of an increased frequency with IADPSG criteria. Diabetes Care 35:461–462.
    OpenUrlFREE Full Text
  17. ↵
    1. HAPO Study Cooperative Research Group,
    2. Metzger BE,
    3. Lowe LP,
    4. Dyer AR,
    5. Trimble ER,
    6. Chaovarindr U,
    7. et al.
    (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Kjos SL,
    2. Buchanan TA
    (1999) Gestational diabetes mellitus. N Engl J Med 341:1749–1756.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Crowther CA,
    2. Hiller JE,
    3. Moss JR,
    4. McPhee AJ,
    5. Jeffries WS,
    6. Robinson JS,
    7. et al.
    (2005) Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 352:2477–2486.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Landon MB,
    2. Spong CY,
    3. Thom E,
    4. Carpenter MW,
    5. Ramin SM,
    6. Casey B,
    7. et al.
    (2009) A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361:1339–1348.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    1. Catalano PM,
    2. Tyzbir ED,
    3. Roman NM,
    4. Amini SB,
    5. Sims EA
    (1991) Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol 165:1667–1672.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    1. Barbour LA,
    2. McCurdy CE,
    3. Hernandez TL,
    4. Kirwan JP,
    5. Catalano PM,
    6. Friedman JE
    (2007) Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30(Suppl 2):S112–S119.
    OpenUrlFREE Full Text
  23. ↵
    1. Solomon CG,
    2. Willett WC,
    3. Carey VJ,
    4. Rich-Edwards J,
    5. Hunter DJ,
    6. Colditz GA,
    7. et al.
    (1997) A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 278:1078–1083.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Kim C,
    2. Newton KM,
    3. Knopp RH
    (2002) Gestational Diabetes and the Incidence of Type 2 Diabetes A systematic review. Diabetes Care 25:1862–1868.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Dabelea D,
    2. Pettitt D
    (2001) Intrauterine diabetic environment confers risks for type 2 diabetes mellitus and obesity in the offspring, in addition to genetic susceptibility. J Pediatr Endocrinol Metab 14:1085–1091.
    OpenUrlPubMedWeb of Science
  26. ↵
    1. O’Sullivan J,
    2. Mahan C
    (1964) Criteria for the oral glucose tolerance test in pregnancy. Diabetes 13:278–285.
    OpenUrlPubMedWeb of Science
  27. ↵
    1. Carpenter M,
    2. Coustan DRW
    (1982) Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144:768–773.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. Alberti KG,
    2. Zimmet PZ
    (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539–553.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    1. Committee on Practice Bulletins--Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus
    (2013) Obstet Gynecol 12:406–416.
    OpenUrl
  30. ↵
    1. National Institutes of Health consensus development conference statement: diagnosing gestational diabetes mellitus, March 4-6, 2013
    (2013) Obstet Gynecol 122:358–369.
    OpenUrlCrossRefPubMed
  31. ↵
    1. American Diabetes Association. Standards of Medical Care in Diabetes--2014
    (2014) Diabetes Care 37(Suppl 1):S14–S80.
    OpenUrlFREE Full Text
    1. Canadian Diabetes Association
    (2008) Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada (Canadian Diabetes Association, Toronto (Canada)).
  33. ↵
    1. Jovanovic-Peterson L,
    2. Peterson CM,
    3. Reed GF,
    4. Metzger BE,
    5. Mills JL,
    6. Knopp RH,
    7. et al.
    (1991) Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development--Diabetes in Early Pregnancy Study. Am J Obstet Gynecol 164:103–111.
    OpenUrlCrossRefPubMedWeb of Science
  34. ↵
    1. de Veciana M,
    2. Major CA,
    3. Morgan MA,
    4. Asrat T,
    5. Toohey JS,
    6. Lien JM,
    7. et al.
    (1995) Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 333:1237–1241.
    OpenUrlCrossRefPubMedWeb of Science
  35. ↵
    1. Jovanovič L,
    2. Savas H,
    3. Mehta M,
    4. Trujillo A,
    5. Pettitt DJ
    (2011) Frequent monitoring of A1C during pregnancy as a treatment tool to guide therapy. Diabetes Care 34:53–54.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    1. Metzger BE,
    2. Buchanan TA,
    3. Coustan DR,
    4. de Leiva A,
    5. Dunger DB,
    6. Hadden DR,
    7. et al.
    (2007) Summary and Recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30(Supplement 2):S251–S260.
    OpenUrlFREE Full Text
  37. ↵
    1. Jovanovic L
    (2000) Role of diet and insulin treatment of diabetes in pregnancy. Clin Obstet Gynecol 43:46–55.
    OpenUrlCrossRefPubMedWeb of Science
  38. ↵
    1. American Diabetes Association,
    2. Bantle JP,
    3. Wylie-Rosett J,
    4. Albright AL,
    5. Apovian CM,
    6. Clark NG,
    7. et al.
    (2008) Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care 31:S61–S78.
    OpenUrlFREE Full Text
  39. ↵
    1. Cheng YW,
    2. Chung JH,
    3. Kurbisch-Block I,
    4. Inturrisi M,
    5. Shafer S,
    6. Caughey AB
    (2008) Gestational weight gain and gestational diabetes mellitus: perinatal outcomes. Obstet Gynecol 112:1015–1022.
    OpenUrlCrossRefPubMedWeb of Science
  40. ↵
    1. Rasmussen KM,
    2. Catalano PM,
    3. Yaktine AL
    (2009) New guidelines for weight gain during pregnancy: what obstetrician/gynecologists should know. Curr Opin Obstet Gynecol 21:521–526.
    OpenUrlCrossRefPubMedWeb of Science
  41. ↵
    1. Pettitt DJ,
    2. Ospina P,
    3. Kolaczynski JW,
    4. Jovanovic L
    (2003) Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus. Diabetes Care 26:183–186.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    1. Mecacci F,
    2. Carignani L,
    3. Cioni R,
    4. Bartoli E,
    5. Parretti E,
    6. La Torre P,
    7. et al.
    (2003) Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women. Eur J Obstet Gynecol Reprod Biol 111:19–24.
    OpenUrlCrossRefPubMed
  43. ↵
    1. Mathiesen ER,
    2. Hod M,
    3. Ivanisevic M,
    4. Garcia SD,
    5. Brøndsted L,
    6. Jovanovič L,
    7. et al.
    (2012) Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care 35:2012–2017.
    OpenUrlAbstract/FREE Full Text
  44. ↵
    1. Pollex E,
    2. Moretti ME,
    3. Koren G,
    4. Feig DS
    (2011) Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis. Ann Pharmacother 45:9–16.
    OpenUrlCrossRefPubMed
  45. ↵
    1. Price N,
    2. Bartlett C,
    3. Gillmer M
    (2007) Use of insulin glargine during pregnancy: a case–control pilot study. BJOG 114:453–457.
    OpenUrlCrossRefPubMed
  46. ↵
    1. Elliott BD,
    2. Langer O,
    3. Schenker S,
    4. Johnson RF
    (1991) Insignificant transfer of glyburide occurs across the human placenta. Am J Obstet Gynecol 165:807–812.
    OpenUrlCrossRefPubMedWeb of Science
  47. ↵
    1. Langer O,
    2. Conway DL,
    3. Berkus MD,
    4. Xenakis EM-J,
    5. Gonzales O
    (2000) A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343:1134–1138.
    OpenUrlCrossRefPubMedWeb of Science
  48. ↵
    1. Kahn BF,
    2. Davies JK,
    3. Lynch AM,
    4. Reynolds RM,
    5. Barbour LA
    (2006) Predictors of glyburide failure in the treatment of gestational diabetes. Obstet Gynecol 107:1303–1309.
    OpenUrlCrossRefPubMedWeb of Science
  49. ↵
    1. Chmait R,
    2. Dinise T,
    3. Moore T
    (2004) Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinatol 24:617–622.
    OpenUrlCrossRefPubMed
  50. ↵
    1. Langer O,
    2. Yogev Y,
    3. Xenakis EM,
    4. Rosenn B
    (2005) Insulin and glyburide therapy: dosage, severity level of gestational diabetes, and pregnancy outcome. Am J Obstet Gynecol 192:134–139.
    OpenUrlCrossRefPubMedWeb of Science
  51. ↵
    1. Eyal S,
    2. Easterling TR,
    3. Carr D,
    4. Umans JG,
    5. Miodovnik M,
    6. Hankins GD,
    7. et al.
    (2010) Pharmacokinetics of metformin during pregnancy. Drug Metab Dispos 38:833–840.
    OpenUrlAbstract/FREE Full Text
  52. ↵
    1. Nawaz FH,
    2. Khalid R,
    3. Naru T,
    4. Rizvi J
    (2008) Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome? J Obstet Gynaecol Res 34:832–837.
    OpenUrlCrossRefPubMed
  53. ↵
    1. Bolton S,
    2. Cleary B,
    3. Walsh J,
    4. Dempsey E,
    5. Turner M
    (2009) Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity. Eur J Pediatr 168:203–206.
    OpenUrlCrossRefPubMedWeb of Science
  54. ↵
    1. Rowan JA,
    2. Hague WM,
    3. Gao W,
    4. Battin MR,
    5. Moore MP
    (2008) Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 358:2003–2015.
    OpenUrlCrossRefPubMedWeb of Science
  55. ↵
    1. Gabbe SG,
    2. Gregory RP,
    3. Power ML,
    4. Williams SB,
    5. Schulkin J
    (2004) Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol 103:1229–1234.
    OpenUrlCrossRefPubMedWeb of Science
  56. ↵
    1. Swaminathan K
    (2013) Experience of metformin use in gestational diabetes: Contribution to the debate. Apollo Medicine 10:113–115.
    OpenUrl
  57. ↵
    1. Lurie S,
    2. Insler V,
    3. Hagay ZJ
    (1996) Induction of labor at 38 to 39 weeks of gestation reduces the incidence of shoulder dystocia in gestational diabetic patients class A2. Am J Perinatol 13:293–296.
    OpenUrlCrossRefPubMed
  58. ↵
    1. Flores-le Roux JA,
    2. Sagarra E,
    3. Benaiges D,
    4. Hernandez-Rivas E,
    5. Chillaron JJ,
    6. Puig de Dou J,
    7. et al.
    (2012) A prospective evaluation of neonatal hypoglycaemia in infants of women with gestational diabetes mellitus. Diabetes Res Clin Pract 97:217–222.
    OpenUrlPubMed
  59. ↵
    1. Jovanovic L,
    2. Peterson CM
    (1980) Management of the pregnant, insulin-dependent diabetic woman. Diabetes Care 3:63–68.
    OpenUrlAbstract/FREE Full Text
  60. ↵
    1. Baptiste-Roberts K,
    2. Barone BB,
    3. Gary TL,
    4. Golden SH,
    5. Wilson LM,
    6. Bass EB,
    7. et al.
    (2009) Risk factors for type 2 diabetes among women with gestational diabetes: a systematic review. Am J Med 122:207–214.
    OpenUrlCrossRefPubMed
  61. ↵
    1. Gunderson EP
    (2007) Breastfeeding After Gestational Diabetes Pregnancy Subsequent obesity and type 2 diabetes in women and their offspring. Diabetes Care 30(Supplement 2):S161–S168.
    OpenUrlFREE Full Text
    1. O’Reilly MW,
    2. Avalos G,
    3. Dennedy MC,
    4. O’Sullivan EP,
    5. Dunne F
    (2011) Atlantic DIP: high prevalence of abnormal glucose tolerance post partum is reduced by breast-feeding in women with prior gestational diabetes mellitus. Eur J Endocrinol 165:953–959.
    OpenUrlAbstract/FREE Full Text
  63. ↵
    1. Owen CG,
    2. Martin RM,
    3. Whincup PH,
    4. Smith GD,
    5. Cook DG
    (2006) Does breastfeeding influence risk of type 2 diabetes in later life?A quantitative analysis of published evidence. Am J Clin Nutr 84:1043–1054.
    OpenUrlAbstract/FREE Full Text
  64. ↵
    1. Glueck CJ,
    2. Wang P
    (2007) Metformin before and during pregnancy and lactation in polycystic ovary syndrome. Expert Opin Drug Saf 6:191–198.
    OpenUrlCrossRefPubMedWeb of Science
  65. ↵
    1. Glatstein MM,
    2. Djokanovic N,
    3. Garcia-Bournissen F,
    4. Finkelstein Y,
    5. Koren G
    (2009) Use of hypoglycemic drugs during lactation. Can Fam Physician 55:371–373.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section